Skip to search formSkip to main content

sinenxan A

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Tumor resistance due to multiple mechanisms seriously hinders the efficacy of chemotherapy drugs such as paclitaxel. The most… Expand
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Two types of sinenxan A derivatives with different side chains at C-5 were synthesized and evaluated for their in vitro multidrug… Expand
Is this relevant?
2009
2009
PurposeTo investigate the reversal mechanisms of a novel semisynthetic taxane derivative, Syl611. Syl611 is a structurally… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2004
2004
以生物合成的SinenxanA(SIA)为起始物,在合成1,7,9-trideoxytaxol的路线中,化合物1为关键中间体,研究了以多种不同氧化剂、在不同条件下[1,2],对14-deoxy-SIA的13… Expand
Is this relevant?
2003
2003
AIM To study the microbial transformation of sinenxan A. METHODS Choose two strains of Fungi (Mucor spinosus AS 3.3450 and… Expand
Is this relevant?
2003
2003
14-Deacetoxy-13-oxo sinenxan A (1) was converted to 9α-hydroxy-13-oxo-2α, 5α, 10β-triacetoxy-4(20),11-taxadiene (2) and 10… Expand
Is this relevant?
2003
2003
AIM To design and synthesize a series of new taxoids with a 5-O-sidechain, and to test the multi-drug resistant reversal activity… Expand
Is this relevant?
1998
1998
In order to develop new taxol analogues with possible antitumor properties, sinenxan A (SIA), a new biosynthetic taxoid, was… Expand
Is this relevant?